Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content
Icon showing an arrow hitting the bullseye of a target

Easy deployment1

You can easily control deployment with a rotating thumbwheel that provides auditory feedback.1 The triaxial delivery system controls the stent position and keeps it in place.1

Icon with squiggly lines illustrating a stent

Consistent crush resistance1

The stent design is unique to each size to resist compression forces in different vein anatomies.1 The combination of wall thickness, strut length, and strut width is customized to each diameter to maintain consistent crush resistance.1

Icon of three sheets of paper stacked atop each other

Clinically meaningful evidence2

The inclusion of complex lesions distinguishes ABRE study 36-month results: 44% of stents in the clinical trial (88/200) crossed the inguinal ligament.2

Risks include pain, myocardial infarction, pulmonary embolism, and restenosis of stented segment.

Learn more.

Learn more about the Abre venous self-expanding stent system.

Keep discovering Abre

See the data.

Review the ABRE clinical study 36-month data.

Review the data

References

1

Test data on file with report 10558227DOC_Rev A. Bench testing might not be representative of clinical performance.

2

Black, M.D., Sapoval, Dexter, et al. Three-Year Outcomes of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction